ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vigabatrin API Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-26H11522
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Vigabatrin API Market Research Report 2022
BUY CHAPTERS

Global Vigabatrin API Market Research Report 2025

Code: QYRE-Auto-26H11522
Report
February 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hetero Drugs
Aurobindo Pharma Limited
Intas Pharmaceuticals
Metrochem API Private Limited
SMS Pharmaceuticals
Biophore India Pharmaceuticals Pvt. Ltd.
Divis Laboratories Ltd
Guangzhou Tosun Pharmaceutical
Granules India Limited

Vigabatrin API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Vigabatrin API Market

Vigabatrin API Market

The global market for Vigabatrin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Vigabatrin(CAS：60643-86-9) is a gamma-amino acid having a gamma-vinyl GABA structure.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vigabatrin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vigabatrin API.
The Vigabatrin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vigabatrin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vigabatrin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Vigabatrin API Market Report

Report Metric Details
Report Name Vigabatrin API Market
CAGR 5%
by Type
  • Above 98 %
  • Above 99 %
by Application
  • Tablets
  • Oral Solution
  • Others
Production by Region
  • India
  • China
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hetero Drugs, Aurobindo Pharma Limited, Intas Pharmaceuticals, Metrochem API Private Limited, SMS Pharmaceuticals, Biophore India Pharmaceuticals Pvt Ltd, Divis Laboratories Ltd., Granules India Limited, Guangzhou Tosun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vigabatrin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Vigabatrin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Vigabatrin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Vigabatrin API Market report?

Ans: The main players in the Vigabatrin API Market are Hetero Drugs, Aurobindo Pharma Limited, Intas Pharmaceuticals, Metrochem API Private Limited, SMS Pharmaceuticals, Biophore India Pharmaceuticals Pvt Ltd, Divis Laboratories Ltd., Granules India Limited, Guangzhou Tosun Pharmaceutical

What are the Application segmentation covered in the Vigabatrin API Market report?

Ans: The Applications covered in the Vigabatrin API Market report are Tablets, Oral Solution, Others

What are the Type segmentation covered in the Vigabatrin API Market report?

Ans: The Types covered in the Vigabatrin API Market report are Above 98 %, Above 99 %

1 Vigabatrin API Market Overview
1.1 Product Definition
1.2 Vigabatrin API by Type
1.2.1 Global Vigabatrin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Vigabatrin API by Application
1.3.1 Global Vigabatrin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Oral Solution
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Vigabatrin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Vigabatrin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Vigabatrin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Vigabatrin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Vigabatrin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Vigabatrin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Vigabatrin API, Industry Ranking, 2023 VS 2024
2.4 Global Vigabatrin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Vigabatrin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Vigabatrin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Vigabatrin API, Product Offered and Application
2.8 Global Key Manufacturers of Vigabatrin API, Date of Enter into This Industry
2.9 Vigabatrin API Market Competitive Situation and Trends
2.9.1 Vigabatrin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Vigabatrin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Vigabatrin API Production by Region
3.1 Global Vigabatrin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Vigabatrin API Production Value by Region (2020-2031)
3.2.1 Global Vigabatrin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Vigabatrin API by Region (2026-2031)
3.3 Global Vigabatrin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Vigabatrin API Production Volume by Region (2020-2031)
3.4.1 Global Vigabatrin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Vigabatrin API by Region (2026-2031)
3.5 Global Vigabatrin API Market Price Analysis by Region (2020-2025)
3.6 Global Vigabatrin API Production and Value, Year-over-Year Growth
3.6.1 India Vigabatrin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 China Vigabatrin API Production Value Estimates and Forecasts (2020-2031)
4 Vigabatrin API Consumption by Region
4.1 Global Vigabatrin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Vigabatrin API Consumption by Region (2020-2031)
4.2.1 Global Vigabatrin API Consumption by Region (2020-2025)
4.2.2 Global Vigabatrin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Vigabatrin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Vigabatrin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Vigabatrin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Vigabatrin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Vigabatrin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Vigabatrin API Production by Type (2020-2031)
5.1.1 Global Vigabatrin API Production by Type (2020-2025)
5.1.2 Global Vigabatrin API Production by Type (2026-2031)
5.1.3 Global Vigabatrin API Production Market Share by Type (2020-2031)
5.2 Global Vigabatrin API Production Value by Type (2020-2031)
5.2.1 Global Vigabatrin API Production Value by Type (2020-2025)
5.2.2 Global Vigabatrin API Production Value by Type (2026-2031)
5.2.3 Global Vigabatrin API Production Value Market Share by Type (2020-2031)
5.3 Global Vigabatrin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Vigabatrin API Production by Application (2020-2031)
6.1.1 Global Vigabatrin API Production by Application (2020-2025)
6.1.2 Global Vigabatrin API Production by Application (2026-2031)
6.1.3 Global Vigabatrin API Production Market Share by Application (2020-2031)
6.2 Global Vigabatrin API Production Value by Application (2020-2031)
6.2.1 Global Vigabatrin API Production Value by Application (2020-2025)
6.2.2 Global Vigabatrin API Production Value by Application (2026-2031)
6.2.3 Global Vigabatrin API Production Value Market Share by Application (2020-2031)
6.3 Global Vigabatrin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hetero Drugs
7.1.1 Hetero Drugs Vigabatrin API Company Information
7.1.2 Hetero Drugs Vigabatrin API Product Portfolio
7.1.3 Hetero Drugs Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hetero Drugs Main Business and Markets Served
7.1.5 Hetero Drugs Recent Developments/Updates
7.2 Aurobindo Pharma Limited
7.2.1 Aurobindo Pharma Limited Vigabatrin API Company Information
7.2.2 Aurobindo Pharma Limited Vigabatrin API Product Portfolio
7.2.3 Aurobindo Pharma Limited Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Aurobindo Pharma Limited Main Business and Markets Served
7.2.5 Aurobindo Pharma Limited Recent Developments/Updates
7.3 Intas Pharmaceuticals
7.3.1 Intas Pharmaceuticals Vigabatrin API Company Information
7.3.2 Intas Pharmaceuticals Vigabatrin API Product Portfolio
7.3.3 Intas Pharmaceuticals Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Intas Pharmaceuticals Main Business and Markets Served
7.3.5 Intas Pharmaceuticals Recent Developments/Updates
7.4 Metrochem API Private Limited
7.4.1 Metrochem API Private Limited Vigabatrin API Company Information
7.4.2 Metrochem API Private Limited Vigabatrin API Product Portfolio
7.4.3 Metrochem API Private Limited Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Metrochem API Private Limited Main Business and Markets Served
7.4.5 Metrochem API Private Limited Recent Developments/Updates
7.5 SMS Pharmaceuticals
7.5.1 SMS Pharmaceuticals Vigabatrin API Company Information
7.5.2 SMS Pharmaceuticals Vigabatrin API Product Portfolio
7.5.3 SMS Pharmaceuticals Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 SMS Pharmaceuticals Main Business and Markets Served
7.5.5 SMS Pharmaceuticals Recent Developments/Updates
7.6 Biophore India Pharmaceuticals Pvt Ltd
7.6.1 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Company Information
7.6.2 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Product Portfolio
7.6.3 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Biophore India Pharmaceuticals Pvt Ltd Main Business and Markets Served
7.6.5 Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
7.7 Divis Laboratories Ltd.
7.7.1 Divis Laboratories Ltd. Vigabatrin API Company Information
7.7.2 Divis Laboratories Ltd. Vigabatrin API Product Portfolio
7.7.3 Divis Laboratories Ltd. Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Divis Laboratories Ltd. Main Business and Markets Served
7.7.5 Divis Laboratories Ltd. Recent Developments/Updates
7.8 Granules India Limited
7.8.1 Granules India Limited Vigabatrin API Company Information
7.8.2 Granules India Limited Vigabatrin API Product Portfolio
7.8.3 Granules India Limited Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Granules India Limited Main Business and Markets Served
7.8.5 Granules India Limited Recent Developments/Updates
7.9 Guangzhou Tosun Pharmaceutical
7.9.1 Guangzhou Tosun Pharmaceutical Vigabatrin API Company Information
7.9.2 Guangzhou Tosun Pharmaceutical Vigabatrin API Product Portfolio
7.9.3 Guangzhou Tosun Pharmaceutical Vigabatrin API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.9.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Vigabatrin API Industry Chain Analysis
8.2 Vigabatrin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Vigabatrin API Production Mode & Process Analysis
8.4 Vigabatrin API Sales and Marketing
8.4.1 Vigabatrin API Sales Channels
8.4.2 Vigabatrin API Distributors
8.5 Vigabatrin API Customer Analysis
9 Vigabatrin API Market Dynamics
9.1 Vigabatrin API Industry Trends
9.2 Vigabatrin API Market Drivers
9.3 Vigabatrin API Market Challenges
9.4 Vigabatrin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Hetero Drugs
Aurobindo Pharma Limited
Intas Pharmaceuticals
Metrochem API Private Limited
SMS Pharmaceuticals
Biophore India Pharmaceuticals Pvt. Ltd.
Divis Laboratories Ltd
Guangzhou Tosun Pharmaceutical
Granules India Limited
List of Tables
 Table 1. Global Vigabatrin API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Vigabatrin API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Vigabatrin API Production Capacity (Kg) by Manufacturers in 2024
 Table 4. Global Vigabatrin API Production by Manufacturers (2020-2025) & (Kg)
 Table 5. Global Vigabatrin API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Vigabatrin API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Vigabatrin API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Vigabatrin API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Vigabatrin API as of 2024)
 Table 10. Global Market Vigabatrin API Average Price by Manufacturers (US$/Kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Vigabatrin API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Vigabatrin API, Product Offered and Application
 Table 13. Global Key Manufacturers of Vigabatrin API, Date of Enter into This Industry
 Table 14. Global Vigabatrin API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vigabatrin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Vigabatrin API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Vigabatrin API Production Value Market Share by Region (2020-2025)
 Table 19. Global Vigabatrin API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Vigabatrin API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Vigabatrin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 22. Global Vigabatrin API Production (Kg) by Region (2020-2025)
 Table 23. Global Vigabatrin API Production Market Share by Region (2020-2025)
 Table 24. Global Vigabatrin API Production (Kg) Forecast by Region (2026-2031)
 Table 25. Global Vigabatrin API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Vigabatrin API Market Average Price (US$/Kg) by Region (2020-2025)
 Table 27. Global Vigabatrin API Market Average Price (US$/Kg) by Region (2026-2031)
 Table 28. Global Vigabatrin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 29. Global Vigabatrin API Consumption by Region (2020-2025) & (Kg)
 Table 30. Global Vigabatrin API Consumption Market Share by Region (2020-2025)
 Table 31. Global Vigabatrin API Forecasted Consumption by Region (2026-2031) & (Kg)
 Table 32. Global Vigabatrin API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 34. North America Vigabatrin API Consumption by Country (2020-2025) & (Kg)
 Table 35. North America Vigabatrin API Consumption by Country (2026-2031) & (Kg)
 Table 36. Europe Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 37. Europe Vigabatrin API Consumption by Country (2020-2025) & (Kg)
 Table 38. Europe Vigabatrin API Consumption by Country (2026-2031) & (Kg)
 Table 39. Asia Pacific Vigabatrin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 40. Asia Pacific Vigabatrin API Consumption by Region (2020-2025) & (Kg)
 Table 41. Asia Pacific Vigabatrin API Consumption by Region (2026-2031) & (Kg)
 Table 42. Latin America, Middle East & Africa Vigabatrin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 43. Latin America, Middle East & Africa Vigabatrin API Consumption by Country (2020-2025) & (Kg)
 Table 44. Latin America, Middle East & Africa Vigabatrin API Consumption by Country (2026-2031) & (Kg)
 Table 45. Global Vigabatrin API Production (Kg) by Type (2020-2025)
 Table 46. Global Vigabatrin API Production (Kg) by Type (2026-2031)
 Table 47. Global Vigabatrin API Production Market Share by Type (2020-2025)
 Table 48. Global Vigabatrin API Production Market Share by Type (2026-2031)
 Table 49. Global Vigabatrin API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Vigabatrin API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Vigabatrin API Production Value Market Share by Type (2020-2025)
 Table 52. Global Vigabatrin API Production Value Market Share by Type (2026-2031)
 Table 53. Global Vigabatrin API Price (US$/Kg) by Type (2020-2025)
 Table 54. Global Vigabatrin API Price (US$/Kg) by Type (2026-2031)
 Table 55. Global Vigabatrin API Production (Kg) by Application (2020-2025)
 Table 56. Global Vigabatrin API Production (Kg) by Application (2026-2031)
 Table 57. Global Vigabatrin API Production Market Share by Application (2020-2025)
 Table 58. Global Vigabatrin API Production Market Share by Application (2026-2031)
 Table 59. Global Vigabatrin API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Vigabatrin API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Vigabatrin API Production Value Market Share by Application (2020-2025)
 Table 62. Global Vigabatrin API Production Value Market Share by Application (2026-2031)
 Table 63. Global Vigabatrin API Price (US$/Kg) by Application (2020-2025)
 Table 64. Global Vigabatrin API Price (US$/Kg) by Application (2026-2031)
 Table 65. Hetero Drugs Vigabatrin API Company Information
 Table 66. Hetero Drugs Vigabatrin API Specification and Application
 Table 67. Hetero Drugs Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 68. Hetero Drugs Main Business and Markets Served
 Table 69. Hetero Drugs Recent Developments/Updates
 Table 70. Aurobindo Pharma Limited Vigabatrin API Company Information
 Table 71. Aurobindo Pharma Limited Vigabatrin API Specification and Application
 Table 72. Aurobindo Pharma Limited Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Aurobindo Pharma Limited Main Business and Markets Served
 Table 74. Aurobindo Pharma Limited Recent Developments/Updates
 Table 75. Intas Pharmaceuticals Vigabatrin API Company Information
 Table 76. Intas Pharmaceuticals Vigabatrin API Specification and Application
 Table 77. Intas Pharmaceuticals Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Intas Pharmaceuticals Main Business and Markets Served
 Table 79. Intas Pharmaceuticals Recent Developments/Updates
 Table 80. Metrochem API Private Limited Vigabatrin API Company Information
 Table 81. Metrochem API Private Limited Vigabatrin API Specification and Application
 Table 82. Metrochem API Private Limited Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Metrochem API Private Limited Main Business and Markets Served
 Table 84. Metrochem API Private Limited Recent Developments/Updates
 Table 85. SMS Pharmaceuticals Vigabatrin API Company Information
 Table 86. SMS Pharmaceuticals Vigabatrin API Specification and Application
 Table 87. SMS Pharmaceuticals Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. SMS Pharmaceuticals Main Business and Markets Served
 Table 89. SMS Pharmaceuticals Recent Developments/Updates
 Table 90. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Company Information
 Table 91. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Specification and Application
 Table 92. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Biophore India Pharmaceuticals Pvt Ltd Main Business and Markets Served
 Table 94. Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
 Table 95. Divis Laboratories Ltd. Vigabatrin API Company Information
 Table 96. Divis Laboratories Ltd. Vigabatrin API Specification and Application
 Table 97. Divis Laboratories Ltd. Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Divis Laboratories Ltd. Main Business and Markets Served
 Table 99. Divis Laboratories Ltd. Recent Developments/Updates
 Table 100. Granules India Limited Vigabatrin API Company Information
 Table 101. Granules India Limited Vigabatrin API Specification and Application
 Table 102. Granules India Limited Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Granules India Limited Main Business and Markets Served
 Table 104. Granules India Limited Recent Developments/Updates
 Table 105. Guangzhou Tosun Pharmaceutical Vigabatrin API Company Information
 Table 106. Guangzhou Tosun Pharmaceutical Vigabatrin API Specification and Application
 Table 107. Guangzhou Tosun Pharmaceutical Vigabatrin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Guangzhou Tosun Pharmaceutical Main Business and Markets Served
 Table 109. Guangzhou Tosun Pharmaceutical Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Vigabatrin API Distributors List
 Table 113. Vigabatrin API Customers List
 Table 114. Vigabatrin API Market Trends
 Table 115. Vigabatrin API Market Drivers
 Table 116. Vigabatrin API Market Challenges
 Table 117. Vigabatrin API Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vigabatrin API
 Figure 2. Global Vigabatrin API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Vigabatrin API Market Share by Type: 2024 VS 2031
 Figure 4. Above 98 % Product Picture
 Figure 5. Above 99 % Product Picture
 Figure 6. Global Vigabatrin API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Vigabatrin API Market Share by Application: 2024 VS 2031
 Figure 8. Tablets
 Figure 9. Oral Solution
 Figure 10. Others
 Figure 11. Global Vigabatrin API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Vigabatrin API Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Vigabatrin API Production Capacity (Kg) & (2020-2031)
 Figure 14. Global Vigabatrin API Production (Kg) & (2020-2031)
 Figure 15. Global Vigabatrin API Average Price (US$/Kg) & (2020-2031)
 Figure 16. Vigabatrin API Report Years Considered
 Figure 17. Vigabatrin API Production Share by Manufacturers in 2024
 Figure 18. Global Vigabatrin API Production Value Share by Manufacturers (2024)
 Figure 19. Vigabatrin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Vigabatrin API Revenue in 2024
 Figure 21. Global Vigabatrin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Vigabatrin API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Vigabatrin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)
 Figure 24. Global Vigabatrin API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. India Vigabatrin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Vigabatrin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Global Vigabatrin API Consumption by Region: 2020 VS 2024 VS 2031 (Kg)
 Figure 28. Global Vigabatrin API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 29. North America Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 30. North America Vigabatrin API Consumption Market Share by Country (2020-2031)
 Figure 31. U.S. Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 32. Canada Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 33. Europe Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 34. Europe Vigabatrin API Consumption Market Share by Country (2020-2031)
 Figure 35. Germany Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 36. France Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 37. U.K. Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 38. Italy Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 39. Russia Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 40. Asia Pacific Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 41. Asia Pacific Vigabatrin API Consumption Market Share by Region (2020-2031)
 Figure 42. China Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 43. Japan Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 44. South Korea Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 45. China Taiwan Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 46. Southeast Asia Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 47. India Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 48. Latin America, Middle East & Africa Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 49. Latin America, Middle East & Africa Vigabatrin API Consumption Market Share by Country (2020-2031)
 Figure 50. Mexico Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 51. Brazil Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 52. Turkey Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 53. GCC Countries Vigabatrin API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 54. Global Production Market Share of Vigabatrin API by Type (2020-2031)
 Figure 55. Global Production Value Market Share of Vigabatrin API by Type (2020-2031)
 Figure 56. Global Vigabatrin API Price (US$/Kg) by Type (2020-2031)
 Figure 57. Global Production Market Share of Vigabatrin API by Application (2020-2031)
 Figure 58. Global Production Value Market Share of Vigabatrin API by Application (2020-2031)
 Figure 59. Global Vigabatrin API Price (US$/Kg) by Application (2020-2031)
 Figure 60. Vigabatrin API Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Vigabatrin Market Research Report 2024
Global Gamma Aminobutyric Acid Market Research Report 2024
Global Pregabalin API Market Research Report 2025
Vigabatrin Powder for Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Food Grade γ Aminobutyric Acid Market Research Report 2025
Global Sitagliptin API Market Research Report 2025
Global Gabapentin API Market Research Report 2024
Global γ Aminobutyric Acid Market Research Report 2024
Global 4 Aminobutyric Acid Market Insights Forecast to 2030
Vildagliptin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 4 Aminobutanoic Acid Market Insights Forecast to 2030
Glyburide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sodium Valproate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Saxagliptin API Market Research Report 2024
Global GABA γ Aminobutyric Acid Gummies Market Research Report 2024
Global Ivabradine API Market Research Report 2025
Global GABA Receptor Agonist Drug Market Research Report 2024
Global Galantamine Hydrobromide API Market Research Report 2024
Oxcarbazepine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Indapamide API Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions